Major Updates from the Pharmaceutical Benefits ...

By Danélia Botes

August 22, 2023

The Pharmaceutical Benefits Advisory Committee (PBAC) has made several recommendations for drug listings on the Australian Pharmaceutical Benefits Scheme (PBS) after July 2023 meeting. Some highlights include:

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.